Company / Cost of Revenue
MEDICINOVA INC Cost of Revenue History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.3M
FY2012
5-year range
-
FY2011-FY2012
Trend
+0.0%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2012.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2012, cost of revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2014 | - | - |
| FY2013 | - | - |
| FY2012 | $1.3M | +0.0% |
| FY2011 | $1.3M | - |
As of FY2012 · SEC 10-K · Updated Jun 28, 2026